Transcutaneous Electrical Nerve Stimulation Versus Baclofen in Spasticity:
- 1 August 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 84 (8) , 584-592
- https://doi.org/10.1097/01.phm.0000171173.86312.69
Abstract
Clinical and electrophysiologic comparison of the efficacy of transcutaneous electrical nerve stimulation (TENS) and oral baclofen in the treatment of spasticity. Patients with spinal cord injury and spasticity were included in the study. Ten patients were assigned to oral baclofen and 11 to TENS groups. For the comparison of H-reflex variables, 20 healthy individuals were allocated to a control group. TENS was applied to the tibial nerve for 15 days at a frequency of 100 Hz. Clinical (spasm frequency scale, painful spasm scale, lower limb Ashworth score, clonus score, deep tendon reflex score, plantar stimulation response score) and electrophysiologic evaluations (H-reflex response at the highest amplitude, latency of maximum H-reflex, and ratio of H-reflex response at the highest amplitude to M response at maximum amplitude) of the lower limb and functional evaluations (functional disability score and FIM) were carried out in baclofen and TENS groups before and after treatment. Posttreatment evaluation was made 24 hrs after the 15th session in the TENS group. In addition, clinical spasticity scores and electrophysiologic variables were measured 15 mins after the first application and 15 mins after the 15th session. Significant improvement was detected in lower limb Ashworth score, spasm frequency scale, deep tendon reflex score, functional disability score, and FIM in the baclofen (P = 0.011, P = 0.014, P = 0.025, P = 0.004, and P = 0.005, respectively) and TENS (P = 0.020, P = 0.014, P = 0.025, P = 0.003, and P = 0.003, respectively) group after treatment. Decrease in H-reflex maximum amplitude was significant in the TENS group (P = 0.026). Most marked improvement was observed in the third evaluation, 15 mins after the 15th session, particularly in lower limb Ashworth score (P = 0.006) and H-reflex maximum amplitude (P = 0.006) in the TENS group. The percentage change in clinical, electrophysiologic, and functional variables caused by baclofen was not different from that caused by repeated applications of TENS in the short- and long-term evaluations (P > 0.05). TENS may be recommended as a supplement to medical treatment in the management of spasticity.Keywords
This publication has 15 references indexed in Scilit:
- Mechanisms of baclofen action on spasticityActa Neurologica Scandinavica, 2009
- The Effect of Transcutaneous Electrical Stimulation on Spinal Motor Neuron Excitability in People Without Known Neuromuscular Diseases: The Roles of Stimulus Intensity and LocationPTJ: Physical Therapy & Rehabilitation Journal, 2002
- Physical Modalities Other than Stretch in Spastic HypertoniaPhysical Medicine and Rehabilitation Clinics of North America, 2001
- Quantitative measures of spasticity in post-stroke patientsClinical Neurophysiology, 2000
- Spasticity after traumatic spinal cord injury: Nature, severity, and locationArchives of Physical Medicine and Rehabilitation, 1999
- Clinical assessment of spasticity in spinal cord injury: A multidimensional problemArchives of Physical Medicine and Rehabilitation, 1996
- Stretch Reflex Latencies in Spastic Hemiparetic Subjects are Prolonged After Transcutaneous Electrical Nerve StimulationCanadian Journal of Neurological Sciences, 1993
- Relief of hemiparetic spasticity by TENS is associated with improvement in reflex and voluntary motor functionsElectroencephalography and Clinical Neurophysiology/Evoked Potentials Section, 1992
- Intrathecal baclofen and the H-reflex.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesionsNeurology, 1976